CereVasc fetches $43.9m Series A

CereVasc Inc, a medical device company that focuses on treating patients with hydrocephalus, has raised $43.9 million in Series A financing.

CereVasc Inc, a medical device company that focuses on treating patients with hydrocephalus, has raised $43.9 million in Series A financing. Perceptive Xontogeny Venture Fund and ATON Partners LLC led the round.

Source: Press Release